论文部分内容阅读
Long-term application of levodopa (L-3,4-dihydroxyphenylalanine,L-DOPA) for Parkinson's disease can lead to adverse effects and reduce the amount of dopamine transporter (DAT) in the corpus striatum.The present study attempted to verify whether increa